Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
Bosch, F. X., & de Sanjose, S. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003479 · Cited by 826
Woodman, C. B., Collins, S., Winter, H., Bailey, A., Ellis, J., Prior, P., Yates, M., Rollason, T. P., & Young, L. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04956-4 · Cited by 822
The cervical cancer epidemic that screening has prevented in the UK
Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 808
LORINCZ, A. T., REID, R., JENSON, B. A., GREENBERG, M. D., LANCASTER, W., & KURMAN, R. J. (1992) · Obstetrics & Gynecology · doi:10.1097/00006250-199203000-00002 · Cited by 775
Mills, J. M., & Stier, E. A. (2021) · 50 Studies Every Obstetrician-Gynecologist Should Know · doi:10.1093/med/9780190947088.003.0031 · Cited by 756
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 733
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Jeon, S., Allen-Hoffmann, B. L., & Lambert, P. F. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2989-2997.1995 · Cited by 582
Clifford, G. M., Rana, R. K., Franceschi, S., Smith, J. S., Gough, G., & Pimenta, J. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0812 · Cited by 533
Jeon, S., & Lambert, P. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1654 · Cited by 527
Efficient Intracellular Assembly of Papillomaviral Vectors
Buck, C. B., Pastrana, D. V., Lowy, D. R., & Schiller, J. T. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.751-757.2004 · Cited by 489
Immunological Events in Regressing Genital Warts
Coleman, N., Birley, H. D. L., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D., & Stanley, M. A. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.6.768 · Cited by 479
Duensing, S. M., & Münger, K. (2002) · PubMed · Cited by 464
Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis
Ramoz, N., Rueda, L.-A., Bouadjar, B., Montoya, L.-S., Orth, G., & Favre, M. (2002) · Nature Genetics · doi:10.1038/ng1044 · Cited by 453
Li, B., & Dou, Q. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070047997 · Cited by 446
Joyce, J. G., Tung, J.-S., Przysiecki, C. T., Cook, J. C., Lehman, E. D., Sands, J. A., Jansen, K. U., & Keller, P. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5810 · Cited by 429
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 428
Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., & Galloway, D. A. (1997) · Genes & Development · doi:10.1101/gad.11.16.2090 · Cited by 419
The natural history of type-specific human papillomavirus infections in female university students.
Richardson, H., Kelsall, G., Tellier, P., Voyer, H., Abrahamowicz, M., Ferenczy, A. S., Coutlée, F., & Franco, E. L. (2003) · PubMed · Cited by 409
Klaes, R., Woerner, S. M., Ridder, R., Wentzensen, N., Duerst, M., Schneider, A., Lotz, B., Melsheimer, P., & Doeberitz, M. V. K. (1999) · PubMed · Cited by 407
You, J., Croyle, J. L., Nishimura, A., Ozato, K., & Howley, P. M. (2004) · Cell · doi:10.1016/s0092-8674(04)00402-7 · Cited by 402
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
Evander, M., Frazer, I. H., Payne, E., Qi, Y. M., Hengst, K., & McMillan, N. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2449-2456.1997 · Cited by 390
Peitsaro, P., Johansson, B., & Syrjänen, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.886-891.2002 · Cited by 390
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 382
Jiang, M., & Milner, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205878 · Cited by 369
Duensing, S., & Münger, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.11691 · Cited by 366
Goodwin, E. C., & DiMaio, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12513 · Cited by 362
A27L Protein Mediates Vaccinia Virus Interaction with Cell Surface Heparan Sulfate
Chung, C.-S., Hsiao, J.-C., Chang, Y.-S., & Chang, W. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1577-1585.1998 · Cited by 355
Doorbar, J., Ely, S., Sterling, J., McLean, C., & Crawford, L. (1991) · Nature · doi:10.1038/352824a0 · Cited by 328
Self-citationChapter 8: Human Papillomavirus and Skin Cancer
Pfister, H. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003483 · Cited by 326
Arbeit, J. M., Howley, P. M., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2930 · Cited by 304
Atomic model of the papillomavirus capsid
Modis, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf494 · Cited by 290
Butz, K., Ristriani, T., Hengstermann, A., Denk, C., Scheffner, M., & Hoppe-Seyler, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206894 · Cited by 283
Different Heparan Sulfate Proteoglycans Serve asCellular Receptors for HumanPapillomaviruses
Shafti-Keramat, S., Handisurya, A., Kriehuber, E., Meneguzzi, G., Slupetzky, K., & Kirnbauer, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13125-13135.2003 · Cited by 279
Properties of a non‐tumorigenic human cervical keratinocyte cell line
Stanley, M. A., Browne, H. M., Appleby, M., & Minson, A. C. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430422 · Cited by 267
Cuschieri, K. S., Cubie, H. A., Whitley, M. W., Seagar, A. L., Arends, M. J., Moore, C., Gilkisson, G., & McGoogan, E. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.57.1.68 · Cited by 267
The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses
Bernard, H.-U. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.10.021 · Cited by 267
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2449 · Cited by 267
Straight, S. W., Herman, B., & McCance, D. J. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3185-3192.1995 · Cited by 258
Middleton, K., Peh, W., Southern, S., Griffin, H., Sotlar, K., Nakahara, T., El-Sherif, A., Morris, L., Seth, R., Hibma, M., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10186-10201.2003 · Cited by 255
Self-citationZhou, J., Liu, W. J., Peng, S. W., Sun, X. Y., & Frazer, I. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4972-4982.1999 · Cited by 253
Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins
Helt, A.-M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.2.159 · Cited by 250
Day, P. M., Baker, C. C., Lowy, D. R., & Schiller, J. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404229101 · Cited by 245
Inhibition of Bak-induced apoptosis by HPV-18 E6
Thomas, M., & Banks, L. (1998) · Oncogene · doi:10.1038/sj.onc.1202223 · Cited by 241
Papillomaviruses infect cells via a clathrin-dependent pathway
Day, P. M., Lowy, D. R., & Schiller, J. T. (2003) · Virology · doi:10.1016/s0042-6822(02)00143-5 · Cited by 230
Nguyen, M. L., Nguyen, M. M., Lee, D., Griep, A. E., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6957-6964.2003 · Cited by 229
Chan, W. K., Klock, G., & Bernard, H. U. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3261-3269.1989 · Cited by 207
Human Papillomaviruses and Non-melanoma Skin Cancer
McLaughlin-Drubin, M. E. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.032 · Cited by 207
Day, P. M., Roden, R. B. S., Lowy, D. R., & Schiller, J. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.142-150.1998 · Cited by 205
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
Thomas, M., Laura, R., Hepner, K., Guccione, E., Sawyers, C., Lasky, L., & Banks, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205668 · Cited by 204
Frattini, M. G., Lim, H. B., & Laimins, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3062 · Cited by 202
Fehrmann, F., Klumpp, D. J., & Laimins, L. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2819-2831.2003 · Cited by 202
Masterson, P. J., Stanley, M., Lewis, A. P., & Romanos, M. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7407-7419.1998 · Cited by 196
Trus, B. L., Roden, R. B. S., Greenstone, H. L., Vrhel, M., Schiller, J. T., & Booy, F. P. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-413 · Cited by 195
Steger, G., & Corbach, S. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.50-58.1997 · Cited by 185
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4918 · Cited by 182
Kalantari, M., Calleja-Macias, I. E., Tewari, D., Hagmar, B., Lie, K., Barrera-Saldana, H. A., Wiley, D. J., & Bernard, H.-U. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12762-12772.2004 · Cited by 181
Gage, J. R., Meyers, C., & Wettstein, F. O. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.723-730.1990 · Cited by 180
Life Cycle Heterogeneity in Animal Models of Human Papillomavirus-Associated Disease
Peh, W. L., Middleton, K., Christensen, N., Nicholls, P., Egawa, K., Sotlar, K., Brandsma, J., Percival, A., Lewis, J., Liu, W. J., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10401-10416.2002 · Cited by 179
Self-citationShamanin, V. A., Glover, M., Rausch, C., Proby, C. M., Leigh, I. M., Hausen, H. Z., & de Villiers, E. M. (1994) · PubMed · Cited by 175
Human papillomaviruses and non-melanoma skin cancer
Harwood, C. A., & Proby, C. M. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200204000-00002 · Cited by 173
Wilson, R., Fehrmann, F., & Laimins, L. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6732-6740.2005 · Cited by 173
Human Papillomavirus Types 16, 31, and 58 Use Different Endocytosis Pathways To Enter Cells
Bousarghin, L., Touzé, A., Sizaret, P.-Y., & Coursaget, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.6.3846-3850.2003 · Cited by 172
Antinore, M. J., Birrer, M. J., Patel, D., Nader, L., & McCance, D. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00546.x · Cited by 165
Genther, S. M., Sterling, S., Duensing, S., Münger, K., Sattler, C., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2832-2842.2003 · Cited by 164
Leder, C., Kleinschmidt, J. A., Wiethe, C., & Müller, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9201-9209.2001 · Cited by 161
Interactions between Papillomavirus L1 and L2 Capsid Proteins
Finnen, R. L., Erickson, K. D., Chen, X. S., & Garcea, R. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4818-4826.2003 · Cited by 158
Pater, M. M., Hughes, G. A., Hyslop, D. E., Nakshatri, H., & Pater, A. (1988) · Nature · doi:10.1038/335832a0 · Cited by 158
Wang, Q., Griffin, H. M., Southern, S. A., Jackson, D. J., Martin, A., McIntosh, P. B., Davy, C. E., Masterson, P. J., Walker, P. A., Laskey, P., et al. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.821-833.2004 · Cited by 151
Self-citationBerezutskaya, E., Yu, B., Morozov, A., Raychaudhuri, P., & Bagchi, S. (1997) · PubMed · Cited by 147
Furth, P. A., Choe, W. T., Rex, J. H., Byrne, J. C., & Baker, C. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5278 · Cited by 145
Kim, K., Garner-Hamrick, P. A., Fisher, C., Lee, D., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12450-12459.2003 · Cited by 144
Regression of Canine Oral Papillomas Is Associated with Infiltration of CD4+ and CD8+ Lymphocytes
Nicholls, P. K., Moore, P. F., Anderson, D. M., Moore, R. A., Parry, N. R., Gough, G. W., & Stanley, M. (2001) · Virology · doi:10.1006/viro.2000.0789 · Cited by 140
Papillomavirus Is Resistant to Desiccation
Roden, R. B. S., Lowy, D. R., & Schiller, J. T. (1997) · The Journal of Infectious Diseases · doi:10.1086/516515 · Cited by 137
Hwang, E.-S., Nottoli, T., & Dimaio, D. (1995) · Virology · doi:10.1006/viro.1995.1395 · Cited by 136
Domains controlling cell polarity and proliferation in the Drosophila tumor suppressor Scribble
Zeitler, J., Hsu, C. P., Dionne, H., & Bilder, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200407158 · Cited by 135
Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a
Doorbar, J., & Gallimore, P. H. (1987) · Journal of Virology · doi:10.1128/jvi.61.9.2793-2799.1987 · Cited by 132
Self-citationClonal Selection for Transcriptionally Active Viral Oncogenes during Progression to Cancer
Van Tine, B. A., Kappes, J. C., Banerjee, N. S., Knops, J., Lai, L., Steenbergen, R. D. M., Meijer, C. L. J. M., Snijders, P. J. F., Chatis, P., Broker, T. R., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11172-11186.2004 · Cited by 132
Human Papillomavirus DNA Replication
Conger, K. L., Liu, J., Kuo, S., Chow, L. T., & Wang, T. S. ‐. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2696 · Cited by 126
Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA
Lee, D., Sohn, H., Kalpana, G. V., Choe, J., & Choe, J. (1999) · Nature · doi:10.1038/20966 · Cited by 125
Matthews, K., Leong, C. M., Baxter, L., Inglis, E., Yun, K., Bäckström, B. T., Doorbar, J., & Hibma, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8378-8385.2003 · Cited by 125
Self-citationBarnard, P., Payne, E., & McMillan, N. A. J. (2000) · Virology · doi:10.1006/viro.2000.0584 · Cited by 122
Human Papillomavirus Type 16 E2 Protein Has No Effect on Transcription from Episomal Viral DNA
Bechtold, V., Beard, P., & Raj, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2021-2028.2003 · Cited by 119
Duensing, S., Duensing, A., Flores, E. R., Do, A., Lambert, P. F., & Münger, K. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7712-7716.2001 · Cited by 117
Modulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4
Nakahara, T., Nishimura, A., Tanaka, M., Ueno, T., Ishimoto, A., & Sakai, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10914-10920.2002 · Cited by 116
Expression of the α6 Integrin Confers Papillomavirus Binding upon Receptor-Negative B-Cells
McMillan, N. A. J., Payne, E., Frazer, I. H., & Evander, M. (1999) · Virology · doi:10.1006/viro.1999.9825 · Cited by 115
Nguyen, M. M., Nguyen, M. L., Caruana, G., Bernstein, A., Lambert, P. F., & Griep, A. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.8970-8981.2003 · Cited by 114
Human Papillomavirus Type 16 E1 ∧ E4 Contributes to Multiple Facets of the Papillomavirus Life Cycle
Nakahara, T., Peh, W. L., Doorbar, J., Lee, D., & Lambert, P. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.13150-13165.2005 · Cited by 113
Self-citationIdentification of a G 2 Arrest Domain in the E1∧E4 Protein of Human Papillomavirus Type 16
Davy, C. E., Jackson, D. J., Wang, Q., Raj, K., Masterson, P. J., Fenner, N. F., Southern, S. A., Cuthill, S., Millar, J. B. A., & Doorbar, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9806-9818.2002 · Cited by 109
Self-citationZhang, B., Li, P., Wang, E., Brahmi, Z., Dunn, K. W., Blum, J. S., & Roman, A. (2003) · Virology · doi:10.1016/s0042-6822(03)00103-x · Cited by 108
Loo, Y.-M., & Melendy, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1605-1615.2004 · Cited by 108
Interaction of Bovine Papillomavirus E2 Protein with Brd4 Stabilizes Its Association with Chromatin
McPhillips, M. G., Ozato, K., & McBride, A. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8920-8932.2005 · Cited by 107
The Minor Capsid Protein L2 Contributes to Two Steps in the Human Papillomavirus Type 31 Life Cycle
Holmgren, S. C., Patterson, N. A., Ozbun, M. A., & Lambert, P. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.3938-3948.2005 · Cited by 107
Nishimura, A., Ono, T., Ishimoto, A., Dowhanick, J. J., Frizzell, M. A., Howley, P. M., & Sakai, H. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3752-3760.2000 · Cited by 105
Assembly and Translocation of Papillomavirus Capsid Proteins
Florin, L., Sapp, C., Streeck, R. E., & Sapp, M. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.10009-10014.2002 · Cited by 105
Stern, P. L. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.005 · Cited by 105
Analysis of Human Papillomavirus Type 16 Variants Indicates Establishment of Persistent Infection
Xi, L. F., Demers, G. W., Koutsky, L. A., Kiviat, N. B., Kuypers, J., Watts, D. H., Holmes, K. K., & Galloway, D. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.3.747 · Cited by 105
Stacey, S. N., Jordan, D., Williamson, A. J. K., Brown, M., Coote, J. H., & Arrand, J. R. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7284-7297.2000 · Cited by 103
The role of viral integration in the development of cervical cancer
Yu, T., Ferber, M. J., Cheung, T. H., Chung, T. K. H., Wong, Y. F., & Smith, D. I. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.08.021 · Cited by 102
Dray, M. S., Russell, P., Dalrymple, C., Wallman, N., Angus, G., Leong, A., Carter, J. R., & Cheerala, B. (2005) · Pathology · doi:10.1080/00313020500058607 · Cited by 100
p16INK4A Immunoexpression and HPV In Situ Hybridization Signal Patterns
Kalof, A. N., Evans, M. F., Simmons-Arnold, L., Beatty, B., & Cooper, K. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000155164.78785.c2 · Cited by 99
Nicholls, P. K., Klaunberg, B. A., Moore, R. A., Santos, E. B., Parry, N. R., Gough, G. W., & Stanley, M. (1999) · Virology · doi:10.1006/viro.1999.0060 · Cited by 97
Frattini, M. G., Hurst, S. D., Lim, H. B., Swaminathan, S., & Laimins, L. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.318 · Cited by 95
BRCA1 Interaction with Human Papillomavirus Oncoproteins
Zhang, Y., Fan, S., Meng, Q., Ma, Y., Katiyar, P., Schlegel, R., & Rosen, E. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505124200 · Cited by 93
Han, Y., Loo, Y., Militello, K. T., & Melendy, T. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4899-4907.1999 · Cited by 91
Human Papillomaviruses and Skin Cancer
Smola, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_10 · Cited by 90
Titolo, S., Pelletier, A., Sauvé, F., Brault, K., Wardrop, E., White, P. W., Amin, A. A., Cordingley, M. G., & Archambault, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5282-5293.1999 · Cited by 90
Stubenrauch, F., Lim, H. B., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1071-1077.1998 · Cited by 90
Codon usage bias and A+T content variation in human papillomavirus genomes
Zhao, K., Liu, W. J., & Frazer, I. H. (2003) · Virus Research · doi:10.1016/j.virusres.2003.08.019 · Cited by 88
Nuclear Translocation of Papillomavirus Minor Capsid Protein L2 Requires Hsc70
Florin, L., Becker, K. A., Sapp, C., Lambert, C., Sirma, H., Müller, M., Streeck, R. E., & Sapp, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5546-5553.2004 · Cited by 87
Lin, B. Y., Makhov, A. M., Griffith, J. D., Broker, T. R., & Chow, L. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6592-6604.2002 · Cited by 86
Human Papillomavirus Type 31b Infection of Human Keratinocytes Does Not Require Heparan Sulfate
Patterson, N. A., Smith, J. L., & Ozbun, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6838-6847.2005 · Cited by 85
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
Griffin, H. M., Elston, R., Jackson, D. J., Ansell, K. H., Coleman, M. M., Winter, G. P., & Doorbar, J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.077 · Cited by 84
Self-citationPhenotypical characterization of lymphocytes infiltrating regressing papillomas
Knowles, G., O'neil, B. W., & Campo, M. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8451-8458.1996 · Cited by 84
Kinetics of in vitro adsorption and entry of papillomavirus virions
Culp, T. D., & Christensen, N. D. (2003) · Virology · doi:10.1016/j.virol.2003.11.004 · Cited by 83
Zhao, X., Rush, M., & Schwartz, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.10888-10905.2004 · Cited by 81
DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins
Hines, C. S., Meghoo, C., Shetty, S., Biburger, M., Brenowitz, M. D., & Hegde, R. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1578 · Cited by 80
Davy, C. E., Jackson, D. J., Raj, K., Peh, W. L., Southern, S. A., Das, P., Sorathia, R., Laskey, P., Middleton, K., Nakahara, T., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.3998-4011.2005 · Cited by 80
Self-citationInfectious human papillomavirus type 18 pseudovirions
Stauffer, Y., Raj, K., Masternak, K., & Beard, P. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2113 · Cited by 77
Peh, W. L., Brandsma, J. L., Christensen, N. D., Cladel, N. M., Wu, X., & Doorbar, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.2142-2151.2004 · Cited by 76
Self-citationInteraction of tSNARE Syntaxin 18 with the Papillomavirus Minor Capsid Protein Mediates Infection
Bossis, I., Roden, R. B. S., Gambhira, R., Yang, R., Tagaya, M., Howley, P. M., & Meneses, P. I. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6723-6731.2005 · Cited by 76
McPhillips, M. G., Veerapraditsin, T., Cumming, S. A., Karali, D., Milligan, S. G., Boner, W., Morgan, I. M., & Graham, S. V. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10598-10605.2004 · Cited by 76
Sherman, L., Jackman, A., Itzhaki, H., Stöppler, M. C., Koval, D., & Schlegel, R. (1997) · Virology · doi:10.1006/viro.1997.8778 · Cited by 74
Disbrow, G. L., Hanover, J. A., & Schlegel, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5839-5846.2005 · Cited by 72
Positively Charged Termini of the L2 Minor Capsid Protein Are Necessary for Papillomavirus Infection
Roden, R. B. S., Day, P. M., Bronzo, B. K., Yutzy, W. H., Yang, Y., Lowy, D. R., & Schiller, J. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10493-10497.2001 · Cited by 72
Bryan, J. T., & Brown, D. R. (2000) · Virology · doi:10.1006/viro.2000.0599 · Cited by 66
Tan, W., & Schwartz, S. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2932-2945.1995 · Cited by 66
Sarafi, T. R., & McBride, A. A. (1995) · Virology · doi:10.1006/viro.1995.1421 · Cited by 65
Zhao, K., Gu, W., Fang, N. X., Saunders, N. A., & Frazer, I. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8643-8655.2005 · Cited by 64
Human papillomaviruses and skin cancer.
Pfister, H. (1992) · PubMed · Cited by 60
Induction of E6/E7 Expression in Cottontail Rabbit Papillomavirus Latency Following UV Activation
Zhang, P., Nouri, M., Brandsma, J. L., Iftner, T., & Steinberg, B. M. (1999) · Virology · doi:10.1006/viro.1999.9950 · Cited by 57
Viruses, chemicals and co-carcinogenesis
Haverkos, H. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207822 · Cited by 57
Genetic Analysis of the Human Papillomavirus Type 31 Differentiation-Dependent Late Promoter
Bodily, J. M., & Meyers, C. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3309-3321.2005 · Cited by 56
Crusius, K., Rodriguez, I., & Alonso, A. (2000) · Virus Genes · doi:10.1023/a:1008112207824 · Cited by 54
Schaeffer, A. J., Nguyen, M. L., Liem, A., Lee, D., Montagna, C., Lambert, P. F., Ried, T., & Difilippantonio, M. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0124 · Cited by 53
Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis
Tate, G., Suzuki, T., Kishimoto, K., & Mitsuya, T. (2004) · Journal of Human Genetics · doi:10.1007/s10038-004-0135-6 · Cited by 51
Fay, A., Yutzy, W. H., Roden, R. B. S., & Moroianu, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13447-13454.2004 · Cited by 49
Dell, G., Wilkinson, K. W., Tranter, R., Parish, J. L., Brady, R. L., & Gaston, K. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.009 · Cited by 49
Spink, K. M., & Laimins, L. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4918-4926.2005 · Cited by 48
Hellberg, D., & Stendahl, U. (2005) · PubMed · Cited by 48
Rabbit Oral Papillomavirus Complete Genome Sequence and Immunity Following Genital Infection
Christensen, N. D., Cladel, N. M., Reed, C. A., & Han, R. (2000) · Virology · doi:10.1006/viro.2000.0237 · Cited by 47
Castle, P. E. (2004) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200407000-00011 · Cited by 45
Symptomatic genital papillomavirus infection in a community
Persson, G., Andersson, K. L., & Krantz, I. (1996) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349609047103 · Cited by 45
Cumming, S. A., McPhillips, M. G., Veerapraditsin, T., Milligan, S. G., & Graham, S. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5167-5177.2003 · Cited by 45
Fujii, T., Masumoto, N., Saito, M., Hirao, N., Niimi, S., Mukai, M., Ono, A., Hayashi, S., Kubushiro, K., Sakai, E., et al. (2005) · Diagnostic Molecular Pathology · doi:10.1097/01.pas.0000162755.84026.9f · Cited by 44
Noya, F., Chien, W.-M., Broker, T. R., & Chow, L. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6121-6134.2001 · Cited by 43
Cumming, S. A., Repellin, C. E., McPhillips, M. G., Radford, J. C., Clements, J. B., & Graham, S. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5993-6003.2002 · Cited by 42
Regulation of human papillomavirus late gene expression.
Schwartz, S. (2000) · PubMed · Cited by 41
Growth and Differentiation of Human Papillomavirus Type 31b Positive Human Cervical Cell Lines
Geest, K. D., Turyk, M. E., Hosken, M. I., Hudson, J. B., Laimins, L. A., & Wilbanks, G. D. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1131 · Cited by 39
BPV1 E2 Protein Enhances Packaging of Full-Length Plasmid DNA in BPV1 Pseudovirions
Zhao, K., Hengst, K., Liu, W., Liu, Y. H., Liu, X. S., McMillan, N. A. J., & Frazer, I. H. (2000) · Virology · doi:10.1006/viro.2000.0348 · Cited by 38
Becker, K. A., Florin, L., Sapp, C., Maul, G. G., & Sapp, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1121-1128.2004 · Cited by 36
Knight, G. L., Grainger, J. R., Gallimore, P. H., & Roberts, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13920-13933.2004 · Cited by 36
Infection by bovine papillomavirus and prospects for vaccination
Campo, M. S. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88889-7 · Cited by 29
Fournier, N., Raj, K., Saudan, P., Utzig, S., Sahli, R., Simanis, V., & Beard, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202775 · Cited by 28
Infection with human papillomavirus alters expression of the small proline rich proteins 2 and 3
Lehr, E. E., Hohl, D., Huber, M., & Brown, D. R. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20011 · Cited by 27
Demeret, C., Goyat, S., Yaniv, M., & Thierry, F. (1998) · Virology · doi:10.1006/viro.1997.9023 · Cited by 24
Combined oral contraceptives and cervical cancer
Moodley, J. (2004) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200402000-00006 · Cited by 19
The 3' region of Human Papillomavirus type 16 early mRNAs decrease expression
Vinther, J., Rosenstierne, M. W., Kristiansen, K., & Norrild, B. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-83 · Cited by 14
Two distinct regions of the BPV1 E1 replication protein interact with the activation domain of E2
Moscufo, N., Sverdrup, F. M., Breiding, D. E., & Androphy, E. J. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00113-6 · Cited by 14
(1996) · PubMed
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
“the infection of a basal stem cell (rather than a basal transiently amplifying cell) and that the longevity of the stem cells is a key factor in the formation of a persistent lesion [3,50,91,92].”
BackgroundInfluentialSelf-citationRegulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
“The importance of MDM2 and MDM4 antagonists In many tumours that express wild-type p53, the function of p53 can be compromised by viral oncogenes such as the papillomavirus E6 and adenovirus E1B proteins that induce p53 degradatio”
BackgroundThe natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.